STTR Phase I: Simultaneous Broadband and Highly Efficient Wireless Powering and Communication of Wearable Wireless Sensors

这个项目更广泛的影响/商业潜力将超越可穿戴传感器。该项目预计将在健康和生活质量方面产生重大的社会效益，因为拟议的技术将能够支持新型无线系统的安全供电和通信，从而实现下一代应用；包括老年人辅助生活的植入式或可穿戴生物监测、起搏器、药物输送、人造器官、残疾人和受伤军人的仿生学，以及癌症和脑部疾病的新疗法。该项目还有望彻底改变其他商业应用，例如用于结构健康监测和环境监测的无线传感器。此外，该项目预计将通过无线供电和外联工作的高级设计项目，扩大代表性不足群体的参与。这项小型企业技术转移研究（STTR）第一阶段项目将产生所需的技术知识，用于开发第一个小型化无线电力传输系统，该系统可以同时安全地向可穿戴设备和传感器传输电力并与之通信，具有前所未有的电力传输效率、带宽和对准不敏感特性。因此，该项目有望对新型和/或适形可穿戴无电池设备的开发产生重大影响，这些设备支持新型生物监测、诊断技术和疗法，并增强我们预防和治疗疾病的能力。该项目还有望导致第一代真正自主的无线植入式设备，用于各种应用，如智能药物激活，人工器官增强性能和状态监测。

The broader impact/commercial potential of this project will go beyond wearable sensors. This project is expected to yield significant societal benefits on health and quality of life, as the proposed technology will be able to support the safe powering and communication of novel wireless systems that will enable next generation applications; including, implantable or wearable biomonitoring of senior people in assisted living, pacemakers, drug delivery, artificial organs, bionics for people with disabilities and injured military personnel, and novel treatments for cancer and brain disorders. This project is also expected to revolutionize other commercial applications, such as, wireless sensors for structural health monitoring and environmental monitoring. In addition, this project is expected to broaden broadening the participation of underrepresented groups through Senior Design projects on wireless powering and outreach efforts.This Small Business Technology Transfer Research (STTR) Phase I project will generate the required technological knowledge for deriving the first miniaturized wireless power transfer systems, which can simultaneously and safely transmit power to and communicate with wearable devices and sensors, with unprecedented power transfer efficiency, bandwidth and alignment-insensitive characteristics. Therefore, this project is expected to have a significant impact on the development of new and/or conformal wearable battery-less devices that support novel biomonitoring, diagnostic techniques and therapies and enhancing our capabilities for disease prevention and treatment. This project is also expected to lead to the first generation of truly autonomous wireless implantable devices for various applications such as smart medicine activation, artificial organ enhanced performance and status monitoring.